Advanced Biomed is trading 14.76% up at $2.41, with the biotech-sector rally potentially providing support. - The price compares with the November 4 close of $2.10; Advanced Biomed also rose in after-hours trading on November 4, when coverage said no direct reason had been established. - No new company-specific announcement explaining the November 5 move surfaced in the search. - Supplied sector context reports XBI up 2.08% pre-market, alongside optimism following Amgen’s earnings and raised outlook.